Apyx Medical (APYX) Free Cash Flow Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.39% |
| Dec 31, 2025 | -14.82% |
| Sep 30, 2025 | -9.09% |
| Jun 30, 2025 | 21.79% |
| Mar 31, 2025 | 36.78% |
| Dec 31, 2024 | 1.75% |
| Sep 30, 2024 | 2.10% |
| Jun 30, 2024 | 5.06% |
| Mar 31, 2024 | -4.14% |
| Dec 31, 2023 | 33.86% |
| Sep 30, 2023 | 40.30% |
| Jun 30, 2023 | -45.58% |
| Mar 31, 2023 | -9.81% |
| Dec 31, 2022 | -60.60% |
| Sep 30, 2022 | -46.54% |
| Jun 30, 2022 | -40.25% |
| Mar 31, 2022 | -10.67% |
| Dec 31, 2021 | 28.87% |
| Sep 30, 2021 | -133.83% |
| Jun 30, 2021 | -106.84% |
| Mar 31, 2021 | 0.39% |
| Dec 31, 2020 | -10.89% |
| Sep 30, 2020 | -27.27% |
| Jun 30, 2020 | -15.07% |
| Mar 31, 2020 | -29.67% |
| Dec 31, 2019 | -98.43% |
| Sep 30, 2019 | -62.71% |
| Jun 30, 2019 | -76.15% |
| Mar 31, 2019 | -35.88% |
| Dec 31, 2018 | -64.36% |
| Mar 31, 2018 | -26.56% |
| Dec 31, 2017 | 30.85% |
| Sep 30, 2017 | -12.19% |
| Jun 30, 2017 | -26.89% |
| Mar 31, 2017 | -31.71% |
| Dec 31, 2016 | -14.38% |
| Sep 30, 2016 | 27.52% |
| Jun 30, 2016 | -16.03% |
| Mar 31, 2016 | -40.40% |